Compare Enveric Biosciences Inc (ENVB) vs Harmony Gold Mining Co. (HMY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Harmony Gold Mining Co. — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.80M), while Harmony Gold Mining Co. trades at $16.64 (market cap $10.02B). The key difference: Harmony Gold Mining Co. is far larger — about 1473.5× Enveric Biosciences Inc's market cap, and Harmony Gold Mining Co. pays a 4.63% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Harmony Gold Mining Co. for 45 Days on average.
| ENVB | HMY | |
|---|---|---|
Market Cap | $6.80M | $10.02B |
Volume | 64,867 | 3,643,683 |
Sector | Health | Basic Materials |
52-Week High | $10.80 | $26.04 |
52-Week Low | $1.27 | $13.32 |
Typical Hold Time | 14 Days | 45 Days |
Enterprise Value | -$1.49M | $10.07B |
Dividend Yield | — | 4.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.495 with a 1.7% daily gain, showing technical bearish signals despite recent earnings beats. The company reported no revenue in 2025 with significant losses (-$8.77M net income), though valuation metrics appear low (EV/EBITDA 0.17, P/B 0.84). Recent news highlights patent approvals and positive preclinical data for non-hallucinogenic therapeutics.
The outlook remains speculative given the lack of revenue and substantial losses, offset by strong analyst support (75% buy rating) and promising drug development progress. Key risks include funding needs and clinical trial outcomes, while institutional sentiment appears cautiously optimistic about long-term pipeline potential.
HMY trades at $16.49, down 4.79% today, amid a bearish technical signal. The stock shows strong fundamentals with a P/E of 5.93, net income margin of 29.57%, and robust cash flow growth, though recent earnings have missed expectations. Harmony Gold is diversifying into copper, with record fiscal 2026 results driven by higher gold prices.
The outlook is mixed: valuation appears attractive, and copper expansion offers long-term growth, but near-term technical weakness and earnings misses pose risks. Analyst consensus is cautious with 70% hold ratings. Key risks include commodity price volatility and execution of growth projects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Harmony Gold Mining Co.
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
Read more on HMY →
